statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CFO Alison Bauerlein sold 10,123 shares of Sight Sciences stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an...

Sight Sciences, Inc. (NASDAQ:SGHT) CFO Sells $51,424.84 in Stock

Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Jeremy B. Hayden sold 4,893 shares of the firm's stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an...

Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $24,856.44 in Stock

Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) COO Sam Boong Park sold 3,414 shares of the stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $5.08...

Sight Sciences, Inc. (NASDAQ:SGHT) COO Sam Boong Park Sells 3,414 Shares

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Sight Sciences to present GEMINI trial data at ASCRS

Gagnants
Le titre OneMedNet (NASDAQ:ONMD) a mont mardi de 60,69% 1,27 dollars lors de la session after-market.
L'action Aesthetic Medical Intl (NASDAQ:AIH) a mont de 37,86% 0,47...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 02/04/2024

Clinical results demonstrate long-term efficacy of the OMNI Surgical System for primary open-angle glaucoma and support use of TearCare technology as a primary treatment for dry eye disease...

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Shares of Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) rose 0.6% during trading on Monday . The stock traded as high as $5.44 and last traded at $5.31. Approximately 41,532 shares traded...

Sight Sciences (NASDAQ:SGHT) Trading 0.6% Higher

MENLO PARK, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ( Sight Sciences or the Company ), an eyecare technology company focused on developing and...

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference

In recent trading, shares of Sight Sciences Inc (SGHT) have crossed above the average analyst 12-month target price of 4.70, changing hands for 4.71/share. When a stock reaches the target...

SGHT Crosses Above Average Analyst Target

Sight Sciences (NASDAQ:SGHT  Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus...

Sight Sciences (NASDAQ:SGHT) Releases Quarterly  Earnings Results, Beats Expectations By $0.13 EPS

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Volume	51,469.00
52-Wk High	$11.20
52-Wk Low	$1.04

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.28	--	--	N/A
Q4'23	-$0.32	-$0.22	30.72%	BEAT
Q3'23	-$0.32	-$0.27	15.07%	BEAT
Q2'23	-$0.34	-$0.30	12.19%	BEAT
Q1'23	-$0.39	-$0.35	10.59%	BEAT

SGHT Sight Sciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals